| Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a … F Costa, D Van Klaveren, S James, D Heg, L Räber, F Feres, T Pilgrim, ... The Lancet 389 (10073), 1025-1034, 2017 | 1030 | 2017 |
| Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients … V Farooq, D Van Klaveren, EW Steyerberg, E Meliga, Y Vergouwe, ... The Lancet 381 (9867), 639-650, 2013 | 890 | 2013 |
| Carotid intima-media thickness for cardiovascular risk assessment: systematic review and meta-analysis SCH van den Oord, EJG Sijbrands, GL ten Kate, D van Klaveren, ... Atherosclerosis 228 (1), 1-11, 2013 | 374 | 2013 |
| Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects DM Kent, E Steyerberg, D Van Klaveren Bmj 363, 2018 | 345 | 2018 |
| Alternative fistula risk score for pancreatoduodenectomy (a-FRS): design and international external validation TH Mungroop, LB Van Rijssen, D Van Klaveren, FJ Smits, ... Annals of surgery 269 (5), 937-943, 2019 | 311 | 2019 |
| Prevention of incisional hernia with prophylactic onlay and sublay mesh reinforcement versus primary suture only in midline laparotomies (PRIMA): 2-year follow-up of a … AP Jairam, L Timmermans, HH Eker, RE Pierik, D van Klaveren, ... The Lancet 390 (10094), 567-576, 2017 | 294 | 2017 |
| The predictive approaches to treatment effect heterogeneity (PATH) statement DM Kent, JK Paulus, D Van Klaveren, R D'Agostino, S Goodman, ... Annals of internal medicine 172 (1), 35-45, 2020 | 269 | 2020 |
| Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting F Costa, D Van Klaveren, F Feres, S James, L Räber, T Pilgrim, MK Hong, ... Journal of the American College of Cardiology 73 (7), 741-754, 2019 | 252 | 2019 |
| Health-related quality of life after TBI: a systematic review of study design, instruments, measurement properties, and outcome S Polinder, JA Haagsma, D van Klaveren, EW Steyerberg, EF Van Beeck Population health metrics 13, 1-12, 2015 | 235 | 2015 |
| Postoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnant JK Wiggers, BG Koerkamp, KP Cieslak, A Doussot, D van Klaveren, ... Journal of the American College of Surgeons 223 (2), 321-331. e1, 2016 | 202 | 2016 |
| Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary … K Takahashi, PW Serruys, V Fuster, ME Farkouh, JA Spertus, DJ Cohen, ... The Lancet 396 (10260), 1399-1412, 2020 | 142 | 2020 |
| Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: the SYNTAX trial at 5-year follow-up YJ Zhang, J Iqbal, D Van Klaveren, CM Campos, DR Holmes, ... Journal of the American College of Cardiology 65 (11), 1107-1115, 2015 | 124 | 2015 |
| Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main … CM Campos, D van Klaveren, V Farooq, CA Simonton, AP Kappetein, ... European heart journal 36 (20), 1231-1241, 2015 | 119 | 2015 |
| The predictive approaches to treatment effect heterogeneity (PATH) statement: explanation and elaboration DM Kent, D Van Klaveren, JK Paulus, R D'Agostino, S Goodman, ... Annals of internal medicine 172 (1), W1-W25, 2020 | 118 | 2020 |
| A novel less-invasive approach for axillary staging after neoadjuvant chemotherapy in patients with axillary node-positive breast cancer by combining radioactive iodine seed … TJA van Nijnatten, JM Simons, ML Smidt, CC van der Pol, PJ van Diest, ... Clinical breast cancer 17 (5), 399-402, 2017 | 114 | 2017 |
| Graphical calibration curves and the integrated calibration index (ICI) for survival models PC Austin, FE Harrell Jr, D van Klaveren Statistics in Medicine 39 (21), 2714-2742, 2020 | 110 | 2020 |
| Risk-targeted lung cancer screening: a cost-effectiveness analysis V Kumar, JT Cohen, D van Klaveren, DI Soeteman, JB Wong, ... Annals of internal medicine 168 (3), 161-169, 2018 | 106 | 2018 |
| Differences between men and women in treatment and outcome after traumatic brain injury A Mikolić, D van Klaveren, JO Groeniger, EJA Wiegers, HF Lingsma, ... Journal of neurotrauma 38 (2), 235-251, 2021 | 104 | 2021 |
| Predictive performance of SYNTAX Score II in patients with left main and multivessel coronary artery disease–analysis of CREDO-Kyoto registry– CM Campos, D van Klaveren, J Iqbal, Y Onuma, YJ Zhang, ... Circulation Journal 78 (8), 1942-1949, 2014 | 91 | 2014 |
| The influence of poor health on competing exit routes from paid employment among older workers in 11 European countries KG Reeuwijk, D van Klaveren, RM van Rijn, A Burdorf, SJW Robroek Scandinavian journal of work, environment & health, 24-33, 2017 | 83 | 2017 |
